- Syros Pharmaceuticals (NASDAQ:SYRS): Q1 EPS of -$0.48 misses by $0.09.
- Revenue of $0.37M (-66.4% Y/Y) misses by $3.68M.
- Press Release
Syros Pharmaceuticals misses by $0.09, misses on revenue
Recommended For You
More Trending News
About SYRS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SYRS | - | - |
Syros Pharmaceuticals, Inc. |